<!doctype html>
<html>
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">

    <title>reveal.js</title>

    <link rel="stylesheet" href="reveal.js/dist/reset.css">
    <link rel="stylesheet" href="reveal.js/dist/reveal.css">
    <link rel="stylesheet" href="reveal.js/dist/theme/simple.css" id="theme">
    <!--<link rel="stylesheet" href="dist/main.css">-->
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">

    <!-- Theme used for syntax highlighted code -->
    <link rel="stylesheet" href="reveal.js/plugin/highlight/monokai.css" id="highlight-theme">
    <style>
    #banner {position: relative; top: 75px}
    .banner {height: 45px; width: auto;}
    .table-small {width: 70%;}
    .w3-col {display: flex; align-items: center; justify-content: center;}
    .reveal .slide-number {font-size: 24pt; color: #fff}
    </style>
  </head>
  <body>
    <div class="reveal">
      <div class="slides">
        <section>
          <section data-auto-animate>
            <h1 style="font-size: 2em">Thesis Seminar</h1>
            <h2 style="font-size: 1.25em">Sofía Fernández Lozano</h2>
            <h2 style="font-size: 1em">Integrated Program in Neuroscience</h2>
            <div id="banner" class="w3-row-padding w3-white w3-round-xxlarge w3-stretch">
              <div class="w3-col" style="width:40%">
                <img class="banner" src="imgs/nist_logo.png" alt="NIST">
              </div>
              <div class="w3-col w3-red w3-round-xxlarge" style="width:20%">
                <img class="banner" src="imgs/mcgill-logo.svg" alt="McGill">
              </div>
              <div class="w3-col" style="width:40%">
                <img class="banner" src="imgs/neuro_logo.png" alt="Neuro">
              </div>
            </div>
          </section>
          <section data-auto-animate>
            <h1 class="r-fit-text">Hippocampal-to-Ventricle Ratio<br> in Alzheimer's Disease:</h1>
            <h2 class="r-fit-text">Computation, Validation, and Characterization</h2>
            <!--<h2 style="font-size: 1em">Sofía Fernández Lozano</h2>-->
            <div id="banner" class="w3-row-padding w3-white w3-round-xxlarge w3-stretch">
              <div class="w3-col" style="width:40%">
                <img class="banner" src="imgs/nist_logo.png" alt="NIST">
              </div>
              <div class="w3-col w3-red w3-round-xxlarge" style="width:20%">
                <img class="banner" src="imgs/mcgill-logo.svg" alt="McGill">
              </div>
              <div class="w3-col" style="width:40%">
                <img class="banner" src="imgs/neuro_logo.png" alt="Neuro">
              </div>
            </div>
          </section>
        </section>
        <section>
          <section>
            <h1>Background and Related Work</h1>
          </section>
          <!--<section>-->
            <!--<h2>Alzheimer's Disease</h2>-->
            <!--<aside class="notes">-->
              <!--Cognitive decline in this project relates specifically to MCI as in the context of it being a preliminary-->
              <!--stage of AD.<br> Alzheimer’s disease (AD) is a chronic, progressive and ultimately fatal neurological-->
              <!--disorder in which the brain progressively and irreversibly deteriorates, affecting the quality of life of-->
              <!--both the patient their close family members and caregivers.-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section>-->
            <!--<h2 class="w3-xxxlarge">Pathological Nature</h2>-->
            <!--<figure>-->
              <!--<img src="imgs/comps/pathologicalEvolution.png" alt="pathologyEvolution" style="width:100%; max-width:1000px">-->
              <!--<figcaption>-->
                <!--<a href="https://doi.org/10.1038/nrdp.2015.56" class="w3-medium" style="color:gray"> Masters, et al., 2015 </a>-->
              <!--</figcaption>-->
            <!--</figure>-->
            <!--<aside class="notes">-->
              <!--The neuropathology of AD is characterized by: <br>-->
              <!--(1) deposition and accumulation of β-amyloid (Aβ)-->
              <!--peptides, or amyloid/senile plaques between the neuronal extracellular space, <br>-->
              <!---Starts basal portions-->
              <!--of cortex on the medial-temporal-lobe; <br>-->
              <!---Asocciation areas; <br>-->
              <!---All areas including sensory and motor core fields.  <br>-->
              <!--(2) formation of neuronal intracellular neurofibrillary tangles of hyperphosphorylated-->
              <!--tau protein, <br>-->
              <!---Braak Stages I,II: transentorhinal <br>-->
              <!---Braak Stages III,IV: limbic <br>-->
              <!---Braak Stages V,VI: isocortical <br>-->
              <!--(3) neuronal loss, and (4) neuroinflammation (Miziak et al., 2021).-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section>-->
            <!--<h2 class="w3-xxxlarge">Biological affliction precedes symptoms by decades</h2>-->
            <!--<figure>-->
              <!--<img src="imgs/acm1/nature1.png" alt="biomarkers" style="width:100%; max-width:900px">-->
              <!--<figcaption>-->
                <!--<a href="https://doi.org/10.1038/s41380-020-0721-9" class="w3-medium" style="color:gray">-->
                  <!--Zetterberg &amp; Bendlin, 2021-->
                <!--</a>-->
              <!--</figcaption>-->
            <!--</figure>-->
            <!--<aside class="notes">-->
              <!--The first accumulation of Aꞵ in the brain can occur one to two decades before the first appearance of-->
              <!--clinical symptoms (Pluta et al., 2020).  Both CSF/PET amyloid and postmortem studies suggest that a-->
              <!--substantial proportion of cognitively normal subjects present evidence of Aβ accumulation.  The exact-->
              <!--proportion is dependent on age and genetic background of the study cohort, but ranges from approximately-->
              <!--20 to 40% (Sperling et al., 2011).-->

              <!--<br>1) (CSF) and plasma Aβ42/Aβ40 ratio.-->
              <!--<br>2) CSF and plasma tau increases, as a neuronal response to the AB changes.-->
              <!--<br>3) AB PET turns positive.-->
              <!--<br>4) Microglia react and secrete soluble triggering receptor expressed on myeloid cells 2 (sTREM2),-->
              <!--maximum in MCI stage declines in dementia phase.-->
              <!--<br>5) CSF neurogranin (Ng): early marker of synaptic dysfunction; increases  w/amyloid PET.-->
              <!--<br>6) Tau PET +: neurodegeneration and synaptic dysfunction biomarkers (CSF and serum/plama neurofilament-->
              <!--light [NfL], hippocampal volume, and SV2A- and fluorodeoxyglucose [FDG] PET).-->
              <!--<br>7) Astrocytic biomarkers: YKL-40 and glial fibrillary acidic protein [GFAP].-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2 class="w3-xxxlarge">A&beta; plaques accelerate tau spreading and cognitive decline in human AD</h2>-->
            <!--<figure>-->
              <!--<img src="imgs/acm3/ab_tau_spread.png" alt="ab&tau spread" style="width:100%; max-width:900px">-->
              <!--<figcaption>-->
                <!--<a href="https://doi.org/10.1038/s41593-020-0687-6" class="w3-medium" style="color:gray">-->
                  <!--Busch &amp; Hyman, 2020-->
                <!--</a>-->
              <!--</figcaption>-->
            <!--</figure>-->
            <!--<aside class="notes">-->
              <!--Top: Tau tangles (red) in absence of cortical plaques are present in brain stem nuclei (for example, locus-->
              <!--coeruleus) and parahippocampal gyrus of many cognitively normal aged individuals (i.e., those with primary-->
              <!--age-related tauopathy).  In AD, the presence of cortical plaques (blue) correlates with neuronal tau-->
              <!--propagation from the parahippocampal gyrus into neocortical areas, including medial parietal and medial-->
              <!--prefrontal cortex.  Bottom: human AD cases with plaques and tangles show a dramatically enhanced formation-->
              <!--and propagation of bioactive, high-molecular weight forms of tau (right) relative to human cases with-->
              <!--tangles alone (left).-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2 class="w3-xxxlarge">A&beta; and tau: cause and effect, or pathogenic interaction?</h2>-->
            <!--<div class="w3-row-padding w3-stretch">-->
              <!--<div class="w3-half">-->
                <!--<figure>-->
                  <!--<img src="imgs/acm3/ab_tau_spread.png" alt="ab&tau spread" style="width:100%; max-width:900px">-->
                  <!--<figcaption>-->
                    <!--<a href="https://doi.org/10.1038/s41593-020-0687-6" class="w3-medium" style="color:gray">-->
                      <!--Busch &amp; Hyman, 2020-->
                    <!--</a>-->
                  <!--</figcaption>-->
                <!--</figure>-->
              <!--</div>-->
              <!--<div class="w3-half">-->
                <!--<ul class="w3-ul" style="list-style-type: none;">-->
                  <!--<li class="w3-xlarge">-->
                    <!--Changes of A&beta; promote the progression of AD and trigger harmful cascade reactions, including-->
                    <!--tau pathology and neurodegeneration.-->
                  <!--</li>-->
                  <!--<li class="w3-xlarge">-->
                    <!--Except this triggering function, A&beta; and tau act independently without a specific interaction.-->
                  <!--</li>-->
              <!--</div>-->
            <!--<aside class="notes">-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2 class="w3-xxxlarge">A&beta; and tau: cause and effect, or pathogenic interaction?</h2>-->
            <!--<div class="w3-row-padding w3-stretch">-->
              <!--<div class="w3-half">-->
                <!--<figure>-->
                  <!--<img src="imgs/acm3/ab_tau_spread.png" alt="ab&tau spread" style="width:100%; max-width:600px">-->
                  <!--<figcaption>-->
                    <!--<a href="https://doi.org/10.1038/s41593-020-0687-6" class="w3-medium" style="color:gray">-->
                      <!--Busch &amp; Hyman, 2020-->
                    <!--</a>-->
                  <!--</figcaption>-->
                <!--</figure>-->
              <!--</div>-->
              <!--<div class="w3-half">-->
                <!--<ul class="w3-ul" style="list-style-type: none;">-->
                  <!--<li class="w3-xlarge">-->
                    <!--Changes of A&beta; promote the progression of AD and trigger harmful cascade reactions, including-->
                    <!--tau pathology and neurodegeneration.-->
                  <!--</li>-->
                  <!--<li class="w3-xlarge">-->
                    <!--<s>Except this triggering function, A&beta; and tau act independently without a specific interaction.</s>-->
                  <!--</li>-->
                  <!--<li class="w3-xlarge">-->
                    <!--AD may be caused not only by the pathology of A&beta; and tau, but also by the synergy and-->
                    <!--interaction among various pathological processes, which subsequently lead to cognitive decline.-->
                  <!--</li>-->
              <!--</div>-->
            <!--<aside class="notes">-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section>-->
            <!--<h2 class="w3-xxxlarge">Causal mediation analyses in MCI (ADNI; N = 623)</h2>-->
            <!--<figure>-->
              <!--<img src="imgs/acm3/ma_2021_long.png" alt="ma_2021" style="width:100%; max-width:1000px">-->
              <!--<figcaption>-->
                <!--<a href="https://doi.org/10.1186/s13195-021-00943-z" class="w3-medium" style="color:gray">-->
                  <!--Ma, et al., 2021-->
                <!--</a>-->
              <!--</figcaption>-->
            <!--</figure>-->
            <!--<aside class="notes">-->
              <!--MEM: Memory, EF: executive, LAN: language, VS: visuospatial; No evidence that CSF A&beta;42 contributes to-->
              <!--cognitive impairment via modulating other AD pathology in CN.  A&beta; pathology and cognitive impairment-->
              <!--was partially mediated by bl tau (CSF p-tau), and neurodegeneration (CSF t-tau, brain, HC, Entorhinal, and-->
              <!--mid-temporal volumes).  Axonal injury (neurofilament), Synaptic dysfunction (neurogranin), and-->
              <!--neuroinflammation (sTREM2 &amp; YKL-40) were not significant mediators.-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2>Hippocampus</h2>-->
            <!--<div class="w3-row-padding w3-stretch">-->
              <!--<div class="w3-half">-->
                <!--<figure>-->
                  <!--<img src="imgs/comps/alz-brain.png" alt="AD_brain">-->
                  <!--<figcaption>-->
                    <!--<a href="https://www.alz.org/" class="w3-medium" style="color:gray;">-->
                      <!--Alzheimer's Association-->
                    <!--</a>-->
                  <!--</figcaption>-->
                <!--</figure>-->
              <!--</div>-->
              <!--<div class="w3-half">-->
                <!--<ul class="w3-ul" style="list-style-type: none;">-->
                  <!--<li>-->
                    <!--Viable proxy for structural and functional integrity-->
                  <!--</li>-->
                  <!--<li class="fragment">-->
                    <!--High variability in volume across populations-->
                  <!--</li>-->
                <!--</ul>-->
              <!--</div>-->
            <!--</div>-->
            <!--<aside class="notes">-->
              <!--Hippocampus performs an important role in several cognitive processes like memory and perception (Voss et-->
              <!--al., 2017; Zeidman &amp; Maguire, 2016).  Due to its affection in both normal and pathological aging-->
              <!--(Adler et al., 2018),-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2>Hippocampus</h2>-->
            <!--<div class="w3-row-padding w3-stretch">-->
              <!--<div class="w3-half">-->
                <!--<figure>-->
                  <!--<img src="imgs/comps/alz-brain.png" alt="AD_brain">-->
                  <!--<figcaption>-->
                    <!--<a href="https://www.alz.org/" class="w3-medium" style="color:gray;">-->
                      <!--Alzheimer's Association-->
                    <!--</a>-->
                  <!--</figcaption>-->
                <!--</figure>-->
              <!--</div>-->
              <!--<div class="w3-half">-->
                <!--<ul class="w3-ul" style="list-style-type: none;">-->
                  <!--<li>-->
                    <!--Viable proxy for structural and functional integrity-->
                  <!--</li>-->
                  <!--<li>-->
                    <!--25% of youth present hippocampi as small as an average older adult (60-75y)-->
                    <!--<a href="https://doi.org/10.1016/j.neuroimage.2006.09.041" class="w3-medium" style="color:gray;">-->
                      <!--Lupien et al., 2007-->
                    <!--</a>-->
                  <!--</li>-->
                <!--</ul>-->
              <!--</div>-->
            <!--</div>-->
            <!--<aside class="notes">-->
              <!--25% of 18-24y subjects presented hippocampi as small as the average older adult (60-75y)-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h3 class="w3-xxxlarge">Hippocampal normative values</h3>-->
            <!--<figure>-->
              <!--<img src="imgs/comps/nomogramsHC.png" alt="Hc-variability" style="width:100%; max-width:700px">-->
              <!--<figcaption>-->
                <!--<a href="https://doi.org/10.1016/j.nicl.2019.101904" class="w3-medium" style="color:gray">-->
                  <!--Nobis, et al., 2019-->
                <!--</a>-->
              <!--</figcaption>-->
            <!--</figure>-->
            <!--<aside class="notes">-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section>-->
            <!--<h3 class="w3-xxxlarge">Hippocampal measures</h3>-->
            <!--<ul class="w3-ul" style="list-style-type: none;">-->
              <!--<li class="w3-xlarge">-->
                <!--Unnormalized hippocampal volume-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--Hippocampal volume adjusted by intracranial volume-->
              <!--</li>-->
            <!--</ul>-->
          <!--</section>-->
          <!--<section>-->
            <!--<h3 class="w3-xxxlarge">Are all IV-adjustment methods the same?</h3>-->
            <!--<ul class="w3-ul" style="list-style-type: none;">-->
              <!--<li class="w3-xlarge">-->
                <!--<a href="https://doi.org/10.1186/s13293-019-0245-7" style="color:gray">-->
                  <!--Sanchis-Segura, et al. (2019) -->
                <!--</a>-->
                <!--assessed how number, size and direction of sex differences in GMv vary depending on how intracranial-->
                <!--volume variation is statistically handled-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--Sex difference on hippocampal volume changes direction when correcting using the proportion method:-->
              <!--</li>-->
              <!--<ul class="w3-ul" style="list-style-type:none;">-->
                <!--<li class="w3-large">Raw: M&gt;F; <i>d</i>=1.14 (left) &amp; <i>d</i>=0.91 (right)</li>-->
                <!--<li class="w3-large">Proportion: M&lt;F <i>d</i>=-0.5 (left) &amp; <i>d</i>=-0.45 (right)</li>-->
              <!--</ul>-->
              <!--<li class="w3-xlarge">-->
                <!--Sex differences on hippocampal volume disappears entirely when adjusting using other size correction-->
                <!--methods:-->
              <!--</li>-->
              <!--<ul class="w3-ul" style="list-style-type:none;">-->
                <!--<li class="w3-large">Covariate regression</li>-->
                <!--<li class="w3-large">Power-corrected proportion</li>-->
                <!--<li class="w3-large">Residuals adjustment</li>-->
                <!--<li class="w3-large">Subject matching</li>-->
              <!--</ul>-->
            <!--</ul>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h3 class="w3-xxxlarge">Other hippocampal measures</h3>-->
            <!--<ul class="w3-ul" style="list-style-type: none;">-->
              <!--<li class="w3-xlarge">-->
                <!--Hippocampal occupancy-->
                <!--<a href="https://doi.org/10.1212/WNL.0b013e3182343314" class="w3-medium" style="color:gray">-->
                  <!--Heister et al. (2011) -->
                <!--</a>-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--Hippocampal (volumetric) integrity-->
                <!--<a href="https://doi.org/10.3233/JAD-150780" class="w3-medium" style="color:gray">-->
                  <!--Ardekani et al. (2016) -->
                <!--</a>-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--Hippocampal-to-ventricle ratio-->
                <!--<a href="https://doi.org/10.1016/j.neuroimage.2019.116108" class="w3-medium" style="color:gray">-->
                  <!--Schoemaker, et al (2019) -->
                <!--</a>-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--Hippocampal-amygdalo-ventricular atrophy score-->
                <!--<a href="https://doi.org/10.1002/hbm.25850" class="w3-medium" style="color:gray">-->
                  <!--Coup&eacute; et al. (2022) -->
                <!--</a>-->
              <!--</li>-->
            <!--</ul>-->
            <!--<aside class="notes">-->
              <!--Defined as the fraction of tissue found in the region expected to encompass a normal HC<br>-->
              <!--Probabilistic algorithm based on registrations to a priori training data-->
            <!--</aside>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h3 class="w3-xxxlarge">Other hippocampal measures</h3>-->
            <!--<div class="w3-row-padding w3-stretch">-->
              <!--<div class="w3-half">-->
                <!--<figure>-->
                  <!--<img src="imgs/comps/HVR.png" alt="HVR">-->
                  <!--<figcaption>-->
                    <!--<a href="https://doi.org/10.1016/j.neuroimage.2019.116108" class="w3-medium" style="color:gray">-->
                      <!--Schoemaker, et al (2019) -->
                    <!--</a>-->
                  <!--</figcaption>-->
                <!--</figure>-->
              <!--</div>-->
              <!--<div class="w3-half">-->
                <!--<ul class="w3-ul" style="list-style-type: none;">-->
                  <!--<li class="w3-xlarge">-->
                    <!--Hippocampal occupancy-->
                    <!--<a href="https://doi.org/10.1212/WNL.0b013e3182343314" class="w3-medium" style="color:gray">-->
                      <!--Heister et al. (2011) -->
                    <!--</a>-->
                  <!--</li>-->
                  <!--<li class="w3-xlarge">-->
                    <!--Hippocampal (volumetric) integrity-->
                    <!--<a href="https://doi.org/10.3233/JAD-150780" class="w3-medium" style="color:gray">-->
                      <!--Ardekani et al. (2016) -->
                    <!--</a>-->
                  <!--</li>-->
                  <!--<li class="w3-xlarge">-->
                    <!--<b>Hippocampal-to-ventricle ratio</b>-->
                    <!--<a href="https://doi.org/10.1016/j.neuroimage.2019.116108" class="w3-medium" style="color:gray">-->
                      <!--Schoemaker, et al (2019) -->
                    <!--</a>-->
                  <!--</li>-->
                  <!--<li class="w3-xlarge">-->
                    <!--Hippocampal-amygdalo-ventricular atrophy score-->
                    <!--<a href="https://doi.org/10.1002/hbm.25850" class="w3-medium" style="color:gray">-->
                      <!--Coup&eacute; et al. (2022) -->
                    <!--</a>-->
                  <!--</li>-->
                <!--</ul>-->
              <!--</div>-->
            <!--</div>-->
            <!--<aside class="notes">-->
              <!--Ventricular enlargement is a marker of brain atrophy <br>-->
              <!--Used manual segmentation to compute the ratio between prehippocampal CSF and hippocampal volume<br>-->
              <!--HVR showed significantly stronger negative associations with age and was a better predictor of memory-->
              <!--compared to standard hippocampal volume<br>-->
              <!--50+88 CN people 66/65 +/- 4.96/6.42yo <br>Memory: Cue Recall Procedure / Rey Auditory Verbal Learning Task-->
            <!--</aside>-->
          <!--</section>-->
        </section>
        <section>
          <section>
            <h1>Research aims</h1>
          </section>
          <section>
            <iframe src="table-1_demog.html" style="width:100%; height:700px; border:none; overflow:auto;"></iframe>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                Develop an open-source tool to facilitate quality control of MRI
              </li>
              <li class="w3-xxlarge">
                Compare different segmentation techniques for the automatic calculation of HVR
              </li>
              <li class="w3-xxlarge">
                Compare the effect of different volume normalization strategies
              </li>
              <li class="w3-xxlarge">
                Obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR at the stages preceding AD
              </li>
              <li class="w3-xxlarge">
                Evaluate HVR's predicting performance for AD progression
              </li>
            </ol>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                <b>Develop an open-source tool to facilitate quality control of MRI</b>
              </li>
              <li class="w3-xxlarge">
                Compare different segmentation techniques for the automatic
                calculation of HVR
              </li>
              <li class="w3-xxlarge">
                Compare the effect of different volume normalization strategies
              </li>
              <li class="w3-xxlarge">
                Obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR
                at the stages preceding AD
              </li>
              <li class="w3-xxlarge">
                Evaluate HVR's predicting performance for AD progression
              </li>
            </ol>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                <b>Develop an open-source tool to facilitate quality control of MRI</b>
              </li>
              <li class="w3-xxlarge">
                <b>Compare different segmentation techniques for the automatic calculation of HVR</b>
              </li>
              <li class="w3-xxlarge">
                Compare the effect of different volume normalization strategies
              </li>
              <li class="w3-xxlarge">
                Obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR at the stages preceding AD
              </li>
              <li class="w3-xxlarge">
                Evaluate HVR's predicting performance for AD progression
              </li>
            </ol>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                <b>Develop an open-source tool to facilitate quality control of MRI</b>
              </li>
              <li class="w3-xxlarge">
                <b>Compare different segmentation techniques for the automatic calculation of HVR</b>
              </li>
              <li class="w3-xxlarge">
                <u>Explore the complex relationship of AD biomarkers' effect on cognitive impairment</u>
              </li>
              <li class="w3-xxlarge">
                Compare the effect of different volume normalization strategies
              </li>
              <li class="w3-xxlarge">
                Obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR
                at the stages preceding AD
              </li>
              <li class="w3-xxlarge">
                Evaluate HVR's predicting performance for AD progression
              </li>
            </ol>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                <b>Develop an open-source tool to facilitate quality control of MRI</b>
              </li>
              <li class="w3-xxlarge">
                <b>Compare different segmentation techniques for the automatic calculation of HVR</b>
              </li>
              <li class="w3-xxlarge">
                <u>Explore the complex relationship of AD biomarkers' effect on cognitive impairment</u>
              </li>
              <li class="w3-xxlarge">
                <u>Compare the effect of different volume normalization strategies</u>
                &amp; obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR at the stages preceding AD
              </li>
              <li class="w3-xxlarge">
                Evaluate HVR's predicting performance for AD progression
              </li>
            </ol>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                <b>Develop an open-source tool to facilitate quality control of MRI</b>
              </li>
              <li class="w3-xxlarge">
                <b>Compare different segmentation techniques for the automatic calculation of HVR</b>
              </li>
              <li class="w3-xxlarge">
                <u>Explore the complex relationship of AD biomarkers' effect on cognitive impairment</u>
              </li>
              <li class="w3-xxlarge">
                <u>Compare the effect of different volume normalization strategies</u>
                &amp; obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR at the stages preceding AD <b>(?)</b>
              </li>
              <li class="w3-xxlarge">
                Evaluate HVR's predicting performance for AD progression
              </li>
            </ol>
          </section>
          <section data-auto-animate>
            <ol class="w3-ol">
              <li class="w3-xxlarge">
                <b>Develop an open-source tool to facilitate quality control of MRI</b>
              </li>
              <li class="w3-xxlarge">
                <b>Compare different segmentation techniques for the automatic calculation of HVR</b>
              </li>
              <li class="w3-xxlarge">
                <u>Explore the complex relationship of AD biomarkers' effect on cognitive impairment</u>
              </li>
              <li class="w3-xxlarge">
                <u>Compare the effect of different volume normalization strategies</u>
                &amp; obtain normative values of HC volume and HVR
              </li>
              <li class="w3-xxlarge">
                Model the spatiotemporal curves of cognitive function and HVR at the stages preceding AD <b>(?)</b>
              </li>
              <li class="w3-xxlarge">
                <s> Evaluate HVR's predicting performance for AD progression</s>
              </li>
            </ol>
          </section>
        </section>
        <!--<section>-->
          <!--<section data-auto-animate>-->
            <!--<h1>Hypotheses</h1>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2>Hypotheses</h2>-->
            <!--<ul class="w3-ul">-->
              <!--<li class="w3-xlarge">-->
                <!--The calculation of HVR, can be reliably done using automatic-->
                <!--methods of segmentation.-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--HVR will show stronger relationships with memory and age than-->
                <!--conventional HC volume measures in a large cohort of healthy-->
                <!--controls (UKBB).-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--HVR will show better prediction capabilities of cognitive-->
                <!--decline than other HC volume methods in large cohorts of-->
                <!--patients with MCI and mild AD (ADNI, AIBL, HABS).-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--There will be significant differences in HVR spatiotemporal curves-->
                <!--between:-->
              <!--</li>-->
              <!--<ul class="w3-ul w3-large">-->
                <!--<li>Dementia-progressors v No-cognitive-decline;</li>-->
                <!--<li>Amyloid+ v Amyloid-;</li>-->
                <!--<li>APOE4+ v APOE4-.</li>-->
              <!--</ul>-->
            <!--</ul>-->
          <!--</section>-->
          <!--<section data-auto-animate>-->
            <!--<h2>Hypotheses</h2>-->
            <!--<ul class="w3-ul">-->
              <!--<li class="w3-xlarge">-->
                <!--<b>The calculation of HVR, can be reliably done using automatic-->
                  <!--methods of segmentation.</b>-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--<b>HVR will show stronger relationships with memory and age than-->
                  <!--conventional HC volume measures in a large cohort of-->
                  <!--<s>healthy controls (UKBB)</s>-->
                  <!--subjects with MCI, AD, and healthy controls (ADNI).</b>-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--<s>HVR will show better prediction capabilities of cognitive-->
                <!--decline than other HC volume methods in large cohorts of-->
                <!--patients with MCI and mild AD (ADNI, AIBL, HABS).</s>-->
                <!--<u>The relationship between B-amyloid accumulation and cognitive-->
                  <!--decline is mediated by both tau pathology and hippocampal-->
                  <!--neurodegeneration (TRIAD).</u>-->
              <!--</li>-->
              <!--<li class="w3-xlarge">-->
                <!--There will be significant differences in HVR spatiotemporal curves-->
                <!--between:-->
              <!--</li>-->
              <!--<ul class="w3-ul w3-large">-->
                <!--<li>Dementia-progressors v No-cognitive-decline;</li>-->
                <!--<li>Amyloid+ v Amyloid-;</li>-->
                <!--<li>APOE4+ v APOE4-.</li>-->
              <!--</ul>-->
            <!--</ul>-->
          <!--</section>-->
        <!--</section>-->
        <section>
          <h1>Research Progress</h1>
        </section>
        <section>
          <section>
            <h2>AIM 1</h2>
            <p>Develop an open-source tool to facilitate quality control (QC)
            of MRI</p>
          </section>
          <section>
            <h3>Qrater</h3>
            <div class="w3-row-padding w3-stretch">
              <div class="w3-half">
                <img src="imgs/comps/qrater.png" alt="qrater"
                style="width:100%; max-width:900px">
              </div>
              <div class="w3-half">
                <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
                  <li>Docker containerized</li>
                  <li>Centralized and accessible by SSH</li>
                  <li>MySQL database built-in</li>
                  <li>Feature-rich</li>
                </ul>
              </div>
            </div>
          </section>
          <section>
            <h3>Results</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Raw MRI data (N=99; 9 raters)<br>
                <span class="w3-xlarge">
                  Agreement with experienced rater: 59-86% (mean 77%)
                  <br>
                  Qrater vs Traditional QC: comparable speeds
                </span>
              </li>
              <li>Linear-registered MRI data (N=99; 8 raters)<br>
                <span class="w3-xlarge">
                  Agreement with experienced rater: 73-92% (mean 84.75%)
                  <br>
                  Qrater vs Traditional QC: 2-3x faster
                </span>
              </li>
              <li>Skull extracted images (N=1,746; 2 raters)<br>
                <span class="w3-xlarge">
                  Kappa value of 0.83 as inter-rater agreement
                  <br>
                  Qrater vs Traditional QC: 20x faster
                </span>
              </li>
            <aside class="notes">
              Even with the high speeds, we got good consistency between raters
              <br>Raw: expert - 99 v 90 in 63 min; trainee - 99 v 79 in 98 min
              <br>Lreg: expert - 99 v 43 in 36 min; trainee - 99 v 30 in 37 min
              <br>Skull: 1 min traditional vs 3 s qrater
            </aside>
          </section>
          <section>
            <h3>Currently in use...</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>14 registered users</li>
              <li>36 uploaded datasets</li>
              <li>89,628 images</li>
              <li>38,460 ratings</li>
            </ul>
            <aside class="notes">
              Curated acquisition of almost all of ADNI3, and Manuscript on the
              works, to be submitted in the summer.
            </aside>
          </section>
          <section>
            <h3>First manuscript</h3>
            <p>Manuscript was accepted for publication in Aperture Neuro</p>
          </section>
        </section>
        <section>
          <section>
            <h2>AIM 2</h2>
            <p>Compare different segmentation techniques for the automatic
                calculation of HVR</p>
          </section>
          <section>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Available  labels from
                <a href="https://doi.org/10.1016/j.neuroimage.2019.116108"
                   style="color: gray;">Schoemaker, et al.</a>; N = 80</li>
              <li>Baseline data for CN, MCI and AD participants
                from ADNI 1, Go, and 2; N = 1641</li>
              <li>
                Compare different segmentation techniques:
              </li>
              <ul class="w3-ul w3-xlarge" style="padding: 0px 30px">
                <li>Multi-atlas label fusion;
                  <a href="https://doi.org/10.1016/j.neuroimage.2010.04.193"
                     class="w3-large" style="color:gray">
                    Collins &amp; Pruessner, 2010;
                  </a></li>
                <li>Non-local Patch-based segmentation;
                  <a href="https://doi.org/10.1016/j.neuroimage.2010.09.018"
                    class="w3-large" style="color:gray">
                      Coup&eacute;, et al., 2011 </a></li>
                <li>Convolutional Neural Network;
                  <a href="https://doi.org/10.1007/978-3-031-08999-2_27"
                    class="w3-medium" style="color:gray">
                    Fonov, et al., 2022 </a></li>
                <li>FreeSurfer v.4.3, v.5.1, and v.6.0*;
                  <a href="https://doi.org/10.1016/S0896-6273(02)00569-X"
                    class="w3-medium" style="color:gray">
                    Fischl, et al., 2002 </a></li>
              </ul>
            </ul>
          </section>
          <section>
            <h2>Performance comparison</h2>
          </section>
          <section>
            <h3>Dice Kappa on manual segmantations</h3>
            <figure>
              <img src="imgs/acm3/manual-labels_segm_kappa_figure.png"
                   alt="Dice of segmentations"
              style="width:100%; max-width:1000px">
            </figure>
            <aside class="notes">
            </aside>
          </section>
          <section>
            <h3>Correlations of calculated HC volume</h3>
            <figure>
              <img src="imgs/acm3/manual-labels_segm-corr_hcvc.png"
                   alt="Correlations of segmentations"
              style="width:100%; max-width:1000px">
            </figure>
            <aside class="notes">
            </aside>
          </section>
          <section>
            <h3>Bland-altman plots</h3>
            <figure>
              <img src="imgs/acm3/manual-labels_segm-bland-altman_hcvc.png"
                   alt="Bland-altman plots of segmentations"
              style="width:100%; max-width:1000px">
            </figure>
            <aside class="notes">
            </aside>
          </section>
          <section>
            <h2>Application on ADNI data</h2>
          </section>
          <section>
            <h3>Failures on HC segmentations</h3>
            <table class="w3-xlarge">
              <tr>
                <th></th>
                <th>CN (N=501)</th>
                <th>MCI (N=819)</th>
                <th>AD (N=321)</th>
              </tr>
              <tr>
                <th>CNN</th>
                <td>0</td>
                <td>1</td>
                <td>1</td>
              </tr>
              <tr>
                <th>NLPB</th>
                <td>2</td>
                <td>9</td>
                <td>3</td>
              </tr>
              <tr>
                <th>MALF</th>
                <td>3</td>
                <td>8</td>
                <td>13</td>
              <tr>
                <th>FS (v6)</th>
                <td>8</td>
                <td>9</td>
                <td>8</td>
              </tr>
              <tr>
                <th>FS (v4.3 &amp; v5.1)*</th>
                <td>47</td>
                <td>122</td>
                <td>58</td>
              </tr>
            </table>
            <p class="w3-medium" style="color:gray">*For FS v4.3 &amp; v5.1
            we show the number of unreported cases by ADNI</p>
            <aside class="notes">
            </aside>
          </section>
          <section data-auto-animate>
            <h3>Similarity & effect sizes: HCv</h3>
            <figure>
              <img src="imgs/acm3/adni-bl_similarity_hcv_dx.png"
                   alt="Similarity between sex"
              style="width:100%; max-width:1000px">
            </figure>
            <aside class="notes">
            </aside>
          </section>
          <section data-auto-animate>
            <h3>Similarity & effect sizes: HVR</h3>
            <figure>
              <img src="imgs/acm3/adni-bl_similarity_hvr_dx.png"
                   alt="Similarity between sex"
              style="width:100%; max-width:1000px">
            </figure>
            <aside class="notes">
            </aside>
          </section>
          <section data-auto-animate>
            <h3>Correlations with age, RAVLT & ADAS13</h3>
            <figure>
              <img src="imgs/acm3/adni-bl_hcv-hvr_corrs.png"
                   alt="Similarity between sex"
              style="width:100%; max-width:500px">
            </figure>
            <aside class="notes">
            </aside>
          </section>
          <section>
            <h2>Second manuscript</h2>
            <p>Manuscript was submitted to Brain</p>
          </section>
        </section>
        <section>
          <section>
            <h2>AIM 3</h2>
              <p>Explore the complex relationship of AD biomakers' effect
              on cognitive decline</p>
          </section>
          <section>
            <h3>TRIAD cohort</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Dataset of CU, MCI and AD participants</li>
              <ul class="w3-ul w3-xlarge" style="padding: 0px 30px">
                <li>General cognition: Mini-Mental State Examination</li>
                <li>&beta;-amyloid: PET [18F]AZD4694</li>
                <li>Tau: PET [18F]MK6240</li>
                <li>Neurodegeneration: HVR obtained from T1w MRI</li>
                <li>Vascular disease: WMH obtained from FLAIR MRI</li>
              </ul>
              <li> <a href="https://doi.org/10.1002/alz.067924"
                  class="w3-xlarge" style="color:gray">
                  Stevenson, et al., 2022 </a>
              </li>
            </ul>
          </section>
          <section data-auto-animate>
            <h3>Disease progression staging</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li><a href="https://doi.org/10.3389/fdata.2020.00024"
                     style="color:gray"
                     >Raket's </a>statistical disease progression modeling</li>
              <li>Use nonlinear mixed effect models to map observed time
                (e.g. time since baseline) to disease time</li>
              <li>Participants (A&beta;+ only)
                were separated into three groups based on MMSE &amp; ADAS13
                scores:</li>
              <ul class="w3-ul w3-xlarge" style="padding: 0px 30px">
                <li><b>Pre-disease:</b> before disease onset</li>
                <li><b>Early:</b> between 0-3 years after disease onset</li>
                <li><b>Late:</b> 3 years or more after disease onset</li>
              </ul>
            </ul>
          </section>
          <section data-auto-animate>
            <h3>Disease progression staging</h3>
            <table class="w3-xlarge">
              <tr>
                <th></th>
                <th>Pre-disease (N=77)</th>
                <th>Early (N=40)</th>
                <th>Late (N=51)</th>
              </tr>
              <tr>
                <th>Age</th>
                <td>72 (8)</td>
                <td>72 (7)</td>
                <td>67 (10)</td>
              </tr>
              <tr>
                <th>Sex (F/M)</th>
                <td>49/28</td>
                <td>25/15</td>
                <td>27/24</td>
              </tr>
            </table>
            <aside class="notes">
            </aside>
          </section>
          <section data-auto-animate>
            <h3>A&beta; &amp; Tau: ROI selection</h3>
            <ul class="w3-ul w3-xlarge" style="list-style-type:none;">
              <li>A&beta; &amp; Tau PET parcellated into 101 rois from
              <a href="https://doi.org/10.1038/s41597-020-0557-9"
                 style="color:gray"> CerebrA atlas</a></li>
              <li>Feature selection:
                <a href="https://doi.org/10.18637/jss.v036.i11"
                   style="color:gray"> Boruta algorithm</a></li>
              <li>Identify the most important ROIs in the prediction of
                estimated disease timepoint<li>
            </ul>
          </section>
          <section data-auto-animate>
            <h3>A&beta; &amp; Tau: ROI selection</h3>
            <figure>
              <img src="imgs/acm3/boruta-rois_raket.png" alt="boruta rois"
              style="width:100%; max-width:550px">
            </figure>
          </section>
          <section data-auto-animate>
            <h3>Mediation analyses</h3>
            <ul class="w3-ul w3-xlarge" style="list-style-type:none;">
              <li>Model the direct and indirect effects of the different
              AD biomarkers on cognition (MMSE scores)</li>
              <li><a href="https://doi.org/10.18637/jss.v048.i02"
                   style="color:gray">Lavaan R package</a></li>
            </ul>
          </section>
          <section data-auto-animate>
            <h3>Mediation analyses</h3>
            <figure>
              <img src="imgs/acm3/med_hypothesis.png"
                   alt="mediation hypothesis"
              style="width:100%; max-width:1000px">
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_all.png" alt="mediation all"
              style="width:100%; max-width:1000px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  All subjects from the three groups</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_all_sign.png" alt="mediation all sign"
              style="width:100%; max-width:1000px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  All subjects from the three groups;
                  only significant paths</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_healthy.png" alt="mediation healthy"
              style="width:100%; max-width:800px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  Pre-disease subcohort</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_healthy_sign.png"
                   alt="mediation healthy sign"
              style="width:100%; max-width:300px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  Pre-disease subcohort; only significant paths</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_early.png" alt="mediation early"
              style="width:100%; max-width:850px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  Early stages subcohort</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_early_sign.png"
                   alt="mediation early sign"
              style="width:100%; max-width:300px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  Early stages subcohort; only significant paths</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_late.png" alt="mediation late"
              style="width:100%; max-width:900px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  Late stages subcohort</p>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h4>Model fit</h4>
            <figure>
              <img src="imgs/acm3/med_late_sign.png" alt="mediation late sign"
              style="width:100%; max-width:1000px">
              <figcaption>
                <p class="w3-xlarge" style="color:gray">
                  Late stages subcohort; only significant paths</p>
              </figcaption>
            </figure>
          </section>
          <section>
            <h3>Third manuscript</h3>
            <p><u>Work still in progress</u></p>
            <p>I will present preliminary results at AAIC2024</p>
          </section>
        </section>
        <section>
          <section>
            <h2>AIM 4</h2>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Compare the effect of different volume normalization
                strategies</li>
              <li>Obtain normative values of HC volume and HVR</li>
            </ul>
          </section>
          <section>
            <h3>UK Biobank</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>UK Biobank: MRI data of healthy subjects aged 44-82</li>
              <ul class="w3-ul w3-large" style="list-style-type:none;">
                <li>39,677 preprocessed T1w images</li>
                <li>35,351 passed automatic QC and
                  were segmented using CNN from AIM2</li>
              </ul>
              <li>33,219 have memory scores</li>
              <ul class="w3-ul w3-large" style="list-style-type:none;">
                <li>Numeric memory</li>
                <li>Prospective memory</li>
                <li>Pair matching</li>
              </ul>
            </ul>
          </section>
          <section>
            <h3>Compare TIV adjustment methods</h3>
            <ul class="w3-ul w3-xlarge" style="list-style-type:none;">
              <li>Explore the effect of TIV adjustment on
                HCvol (CNN &amp; FreeSurfer) and HVR</li>
              <li>Adjustment methods described in
                <a href="https://doi.org/10.1186/s13293-019-0245-7"
                  style="color:gray">Sanchis-Segura, et al. (2019) </a></li>
              <ul class="w3-ul w3-large" style="list-style-type:none;">
                <li>Scaling from registration (STX)</li>
                <li>Proportion (Vol/TIV; Prop)</li>
                <li>Power-corrected proportion (PCP)</li>
                <li>Residuals adjustment (Res)</li>
              </ul>
            </ul>
          </section>
          <section data-auto-animate>
            <h3>Sex differences</h3>
          </section>
          <section data-auto-animate>
            <h3>Sex differences</h3>
            <table class="w3-xlarge">
              <tr>
                <th></th>
                <th>Males</th>
                <th>Females</th>
              </tr>
              <tr>
                <th>N</th>
                <td>15,876</td>
                <td>19,468</td>
              </tr>
              <tr>
                <th>Age</th>
                <td>64 (7.7)</td>
                <td>63 (7.4)</td>
              </tr>
            </table>
          </section>
          <section data-auto-animate>
            <h3>Sex differences</h3>
            <figure>
              <img src="imgs/acm3/effsizes-sex_hc-dl.png"
              alt="EffSizes-CNN" style="width:100%; max-width:1000px">
              <figcaption>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h3>Sex differences</h3>
            <figure>
              <img src="imgs/acm3/effsizes-sex_hc-fs.png"
              alt="EffSizes-FS" style="width:100%; max-width:1000px">
              <figcaption>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h3>Sex differences</h3>
            <figure>
              <img src="imgs/acm3/effsizes-sex_hvr.png"
              alt="EffSizes-HVR" style="width:100%; max-width:1000px">
              <figcaption>
              </figcaption>
            </figure>
          </section>
          <section data-auto-animate>
            <h3>Relationship with Age, Memory</h3>
          </section>
          <section data-auto-animate>
            <h3>Relationship with Age, <u>Memory</u></h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Confirmatory factor analysis</li>
              <ul class="w3-ul w3-large" style="list-style-type:none;">
                <li>Factor comprising all three instances of Pairs matching</li>
                <li>Global factor of memory from all three memory scores</li>
              </ul>
            </ul>
          </section>
          <section data-auto-animate>
            <h3>Relationship with Age, Memory</h3>
            <figure>
              <img src="imgs/acm3/corrs.png"
              alt="Correlations" style="width:100%; max-width:1000px">
              <figcaption>
              </figcaption>
            </figure>
          </section>
          <section>
            <h3>Fourth manuscript?</h3>
            <p><u>Work still in progress</u></p>
          </section>
          <section>
            <h3>GAMLSS: Normative data</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Generalized additive models for location, scale and shape</li>
              <li>Model growth trajectories of the HC/HVR and estimate non-linear
                age-related trends stratified by sex.
              </li>
              <li>Create an integrated measure of normative deviation by
                computing the Mahalanobis distance across centile scores</li>
            </ul>
            <aside class="notes">
              robust and flexible framework for modelling non-linear growth
              trajectories recommended by the World Health Organization24
              Calculation of individualized centile information for any new
              observation.
              Assess with BIC and bootstrap resampling methods.
            </aside>
          </section>
        </section>
        <section>
          <section data-auto-animate>
            <h2>Future AIM</h2>
            <p>Model the spatiotemporal curves of cognitive function and HVR
            at the stages preceding AD</p>
          </section>
          <section data-auto-animate>
            <h3>PREVENT-AD</h3>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Group-based trajectory model<br>
                <ul class="w3-ul w3-xlarge" style="padding: 0px 30px">
                  <li>Cognitive decline</li>
                  <li>HC atrophy</li>
                  <li>CSF biomarkers</li>
                  <ul class="w3-ul w3-xlarge" style="list-style-type:none;">
                    <li>Amyloid-beta (A&beta;1-42)</li>
                    <li>Total tau (t-Tau)</li>
                    <li>Phosphorylated tau (p-Tau)</li>
                  </ul>
                </ul>
              </li>
              <li>Multinomial logistic regression as a predictive model
              for trajectory subgroup assignment</li>
            </ul>
            <aside class="notes">
              Group-based trajectory models are a specialized application of finite mixture models.
            </aside>
          </section>
        </section>
        <section>
          <section data-auto-animate>
            <h1>Contributions</h1>
          </section>
          <section data-auto-animate>
            <h1 class="w3-jumbo">Contributions</h1>
            <ul class="w3-ul w3-xxlarge" style="list-style-type:none;">
              <li>Open-source Imaging QC software</li>
              <li>Tool for automatic HVR calculation from MRI</li>
              <li>Validation of HVR as proxy of HC atrophy</li>
              <li>Normative Percentile Tables of HC volume and HVR</li>
              <li>More effective identification of the early stages of AD</li>
            </ul>
            <aside class="notes">
              Qrater, an open-source web-application free to use and available
              to download to facilitate Quality Control evaluation of any kind
              of imaging task in a simple to use and collaborative way.
              A tool for the automatic tissue segmentation of the hippocampus
              and its surrounding temporal horn of the lateral ventricle.
              Given the role of the hippocampus in healthy and pathological
              aging, this tool will prove useful for the studies of other
              types of neurodegenerative diseases.
              A new standardized metric for hippocampal volume proved to be
              more capable of capturing its atrophy.
              Normative centile tables stratified by sex of raw hippocampal
              volume and HVR that will provide valuable information regarding
              normal variations of these measures.
              The finding of the distinct possible disease progression
              trajectories in AD and a set of prediction models able to
              identify the risk of a new patient belonging to one of these
              classes.
            </aside>
          </section>
        </section>
      </div>
    </div>

    <script src="reveal.js/dist/reveal.js"></script>
    <script src="reveal.js/plugin/notes/notes.js"></script>
    <script src="reveal.js/plugin/markdown/markdown.js"></script>
    <script src="reveal.js/plugin/highlight/highlight.js"></script>
    <script src="reveal.js/plugin/math/math.js"></script>
    <script>
      // More info about initialization & config:
      // - https://revealjs.com/initialization/
      // - https://revealjs.com/config/
      Reveal.initialize({
        hash: true,
        margin: 0.03,
        slideNumber: "c/t",
        totalTime: 1800,
        // Learn about plugins: https://revealjs.com/plugins/
        plugins: [ RevealMarkdown, RevealHighlight, RevealNotes, RevealMath.KaTeX ]
      });
    </script>
  </body>
</html>
